Track topics on Twitter Track topics that are important to you
NEW YORK, June 1, 2015 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Global Power Equipment Group, Inc. (NYSE:GLPW) between March 9, 2015 and May 6, 2015.
You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of Texas. If you purchased or otherwise acquired Global Power Equipment Group, Inc. ("Global Power") securities between March 9, 2015 and May 6, 2015, your rights may be affected by this action. To get more information go to:
The Complaint alleges that the defendants concealed from the investing public that: (1) the Company's cost of sales in its financial statements for the annual period ended December 31, 2014 were understated; (2) the Company lacked adequate internal controls over its financial reporting; and (3) as a result of the foregoing, the Company's public statements were materially false and misleading at all relevant times.
If you suffered a loss in Global Power Equipment you have until July 13, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.comNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...